Eligard 7.5Mg Inj

Eligard 7.5Mg Inj belongs to the class of synthetic hormones used in the treatment of prostate cancer in men, endometriosis, and hormone-responsive breast cancer in women. Also, Eligard 7.5Mg Inj is used to treat premature puberty in children. Prostate cancer is cancer of the prostate gland (a small gland under the bladder that produces semen) found only in men. The symptoms include difficulty in urination, pain, numbness, or sexual problems.

Eligard 7.5Mg Inj contains Leuprorelin, a synthetic hormone that works similarly to the natural hormone, gonadotropin-releasing hormone (GnRH), by acting on the pituitary gland and decreasing the levels of testosterone in men and estrogen in women. Thereby, Eligard 7.5Mg Inj is used in the treatment of prostate cancer by inhibiting the growth of the tumor or causing it to shrink.  

Use Eligard 7.5Mg Inj as prescribed by your doctor. You are advised to take Eligard 7.5Mg Inj for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience pain, redness, swelling, or skin hardening at the injection site, muscle weakness, bone pain, inability to have an erection, breast tenderness, headache, vaginal dryness, changes in breast size, acne, or mood swings. Most of these side effects of Eligard 7.5Mg Inj do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Eligard 7.5Mg Inj or any other medicines, please tell your doctor. Eligard 7.5Mg Inj is contraindicated in pregnant and breastfeeding women. It is advised to use effective contraceptive measures to avoid pregnancy while taking Eligard 7.5Mg Inj as it may cause birth defects. Eligard 7.5Mg Inj should be used with caution in children. You are recommended to avoid or limit consumption of alcohol with Eligard 7.5Mg Inj as it may increase the risk of bone density loss. Drive only if you are alert as Eligard 7.5Mg Inj may cause dizziness, drowsiness, or vision disturbances.

Eligard 7.5Mg Inj contains Leuprorelin which works similarly to the natural hormone, gonadotropin-releasing hormone (GnRH), by acting on the pituitary gland and decreasing the levels of testosterone in men and oestrogen in women. Thereby, Eligard 7.5Mg Inj is used in the treatment of prostate cancer by inhibiting the growth of the tumour or causing it to shrink.  Also, Eligard 7.5Mg Inj is used to treat hormone-responsive breast cancer in pre and postmenopausal women. By reducing testosterone and oestrogen levels, Eligard 7.5Mg Inj delays the onset of puberty in children.

If you are allergic to Eligard 7.5Mg Inj or any other medicines, please tell your doctor. Eligard 7.5Mg Inj is contraindicated in pregnant and breastfeeding women. It is advised to use effective non-hormonal contraceptives such as condoms to avoid pregnancy while taking Eligard 7.5Mg Inj as it may cause birth defects. Eligard 7.5Mg Inj should be used with caution in children. You are advised to quit smoking as it may increase the risk of prostate cancer. You are recommended to avoid or limit consumption of alcohol with Eligard 7.5Mg Inj as it may increase the risk of bone density loss. Drive only if you are alert as Eligard 7.5Mg Inj may cause dizziness, drowsiness or vision disturbances.

Eligard 7.5Mg Inj may cause changes in blood cholesterol levels or affect values in liver functioning tests. Therefore, inform your doctor that you are taking Eligard 7.5Mg Inj before undergoing any tests.